Organigram Global, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. The company is headquartered in Moncton, New Brunswick and currently employs 1,178 full-time employees. The company went IPO on 2011-11-24. The company has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT, Collective Project, Fetch and DEBUNK. The company operates facilities in Moncton, New Brunswick and LacSuperieur, Quebec, with an edibles manufacturing facility in Winnipeg, Manitoba. The company operates two additional cannabis processing facilities in Southwestern Ontario: one in Aylmer and the other in London. The facility in Aylmer houses CO2 and Hydrocarbon extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London is optimized for labeling, packaging, and national fulfillment. Its subsidiaries include Organigram Inc. and Motif Labs Ltd.
Follow-Up Questions
Who is the CEO of Organigram Global Inc?
Ms. Beena Goldenberg is the Chief Executive Officer of Organigram Global Inc, joining the firm since 2021.
What is the price performance of OGI stock?
The current price of OGI is $1.53, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Organigram Global Inc?
Organigram Global Inc belongs to Pharmaceuticals industry and the sector is Health Care
What is Organigram Global Inc market cap?
Organigram Global Inc's current market cap is $205.0M
Is Organigram Global Inc a buy, sell, or hold?
According to wall street analysts, 5 analysts have made analyst ratings for Organigram Global Inc, including 1 strong buy, 5 buy, 2 hold, 0 sell, and 1 strong sell
